Filing Analysis

📄 Other SEC Filing Filed Nov 15, 2024
⚪ LOW

BioLargo, Inc. filed an 8-K to disclose a slide deck presentation (Exhibit 99.1) shared during a webcast investor conference on November 14, 2024.

📋 Key Facts

  • The company presented slides at an investor conference on November 14, 2024, at 1:30 PM PT.
  • The filing includes a slide deck (Exhibit 99.1) and a press release (Exhibit 99.2).
  • Information provided under Item 7.01 is not considered 'filed' for purposes of liability under Section 18 of the Exchange Act.
📄 Other SEC Filing Filed Aug 15, 2024
⚪ LOW

BioLargo, Inc. filed this 8-K to provide notice of a presentation made during an investor conference on May 14, 2024. The filing includes the slide deck used during that presentation as Exhibit 99.1.

📋 Key Facts

  • The filing relates to information presented at a webcast investor conference on May 14, 2024.
  • Exhibit 99.1 contains the slide deck from said presentation.
  • The disclosure is made pursuant to Item 7.01 (Regulation FD Disclosure).
  • Management states they undertake no duty to update or revise the information provided in the slides.
📄 Other SEC Filing Filed Jun 20, 2024
⚪ LOW

BioLargo, Inc. held its 2024 annual stockholder meeting on June 13, 2024. All proposed items, including the election of seven directors and the ratification of auditors, were approved by shareholders.

📋 Key Facts

  • Annual stockholder meeting held on June 13, 2024.
  • Seven individuals elected to the Board: Dennis P. Calvert, Kenneth R. Code, Dennis E. Marshall, Joseph L. Provenzano, Jack B. Strommen, Linda Park, and Christina Bray.
  • Shareholders approved advisory compensation for named executive officers (96.5% in favor).
  • Ratification of Hacker Johnson & Smith PA as independent registered public accounting firm for the year ending Dec 31, 2024 (98.9% in favor).
  • Approval of the 2024 Equity Incentive Plan (98.9% in favor).
📄 Other SEC Filing Filed Jun 13, 2024
⚪ LOW

BioLargo, Inc. filed an 8-K to provide presentation slides intended for use at its annual stockholder meeting held on June 13, 2024.

📋 Key Facts

  • The filing is pursuant to Item 7.01 (Regulation FD Disclosure).
  • Presentation slides were attached as Exhibit 99.1.
  • The information in the presentation is not considered 'filed' for purposes of Section 18 or liability under Sections 11 and 12(a)(2) of the Securities Act.
  • The company held its annual stockholder meeting on June 13, 2024, at 10:00 am Pacific Time.
📄 Other SEC Filing Filed May 15, 2024
⚪ LOW

BioLargo, Inc. filed an 8-K to provide notice of a presentation at an investor conference on May 14, 2024. The filing includes a slide deck and a press release under Regulation FD disclosure.

📋 Key Facts

  • Company presented slides (Exhibit 99.1) at a webcast investor conference on May 14, 2024, at 2:30 PM PT.
  • The company issued a press release (Exhibit 99.2) simultaneously with the presentation.
  • Information provided under Item 7.01 is not considered 'filed' for purposes of Section 18 of the Exchange Act or liability under Sections 11/12(a)(2) of the Securities Act.
📄 Other SEC Filing Filed Jan 22, 2024
⚪ LOW

BioLargo, Inc. filed an 8-K to provide disclosure pursuant to Regulation FD via a press release issued on January 22, 2024.

📋 Key Facts

  • The filing is made under Item 7.01 (Regulation FD Disclosure).
  • A press release was published on January 22, 2024, and incorporated by reference as Exhibit 99.1.
  • The information provided in the press release is not considered 'filed' for purposes of Section 18 of the Exchange Act or liability under Sections 11/12(a)(2) of the Securities Act.
📄 Other SEC Filing Filed Jan 10, 2024
⚪ LOW

BioLargo, Inc. filed an 8-K to announce its participation in a webcast investor conference hosted by EmergingGrowth.com on January 10, 2024.

📋 Key Facts

  • Company is presenting slides at a webcast investor conference.
  • Conference host: EmergingGrowth.com.
  • Event date/time: January 10, 2024, at 9:00 AM Pacific Time.
  • The presentation is attached as Exhibit 99.1.
🔍 Auditor Change Filed Jan 05, 2024
🟡 MEDIUM

BioLargo, Inc. announced the dismissal of its independent registered public accounting firm, Haskell & White LLP, and the appointment of Hacker Johnson & Smith PA as its new auditor for the fiscal year ending December 31, 2023.

🚩 Red Flags

  • Auditor change in a micro-cap company can sometimes precede restatements or disagreements, though no disagreement was explicitly stated here.

📋 Key Facts

  • Effective January 2, 2024, Hacker Johnson & Smith PA was engaged as the Company's independent registered public accounting firm.
  • Haskell & White LLP was dismissed as the Company's independent registered public accounting firm.
  • The Company stated there were no disagreements with Haskell & White regarding accounting principles, practices, financial statement disclosure, or auditing scope/procedures for fiscal years 2021, 2022, and interim periods through January 2, 2024.
  • No 'reportable events' occurred during the tenure of the previous auditor.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for BLGO

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial